HealthQuill autoimmune disorder
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial and the California-based company has started talks with regulators for its approval.
Drugs Health Pharma

Amgen’s trial drug to fight autoimmune disorder improves patient outcomes

Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.

Read More
After screening 12 million commercially available compounds using AI, researchers at the Massachusetts Institute of Technology have discovered a drug candidate to terminate a potentially fatal skin bacteria.
Drugs Health Medical

Researchers uncover key role of gut cells in triggering gluten allergy

HQ Team August 17, 2024: A team of scientists led by McMaster University in Canada has found that cells lining the gut play.

Read More
X